News

Public health evidence points to need for FDA regulation of...

Public health evidence points to need for FDA regulation of laboratory developed tests

November 18, 2015

November 18, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org Public health evidence points to need for FDA regulation of laboratory developed tests “The consequences of inaccurate test results, such as false positives, can result in the unnecessary removal of a woman’s ovaries. It is critical that patients know their test results can be trusted.” Washington, DC — … Continued

Advocacy

A Statement about LDTs

A Statement about LDTs

November 18, 2015

Washington, DC — On November 17th, the Food and Drug Administration (FDA) released a report: The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies, that outlines the harm that not regulating laboratory developed tests (LDTs) can cause to patients and to the economy. Included in the report were two case studies about … Continued

Advocacy

Meet OCRF’s 2016 Grantees

Meet OCRF’s 2016 Grantees

November 17, 2015

OCRF has awarded $5.2 million in new grants, bringing our total investment in ovarian cancer research to nearly $70 million.

OCRA News

OCRF Research Explains Limits of Cancer Immunotherapy Drugs

OCRF Research Explains Limits of Cancer Immunotherapy Drugs

November 3, 2015

A new study of ovarian cancer cells from the University of Michigan Comprehensive Cancer Center, funded in part by an OCRF grant to Dr. Weiping Zou, reveals molecular changes within the tumor that prevent immunotherapy drugs from killing off the cancer.  The research was published in Nature. Immunotherapy treatments have proven wildly successful in treating … Continued

OCRA News

Research Round Up: AACR

November 3, 2015

Earlier this month, we attended the AACR conference Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, which highlighted many recent pre-clinical advancements in the treatment of ovarian cancer.  Much of the work presented was hot off the presses and unpublished – so we were asked not to share too many details from the work publicly. To … Continued

Research

New Ovarian Cancer National Alliance research finds state l...

New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year

October 16, 2015

For Immediate ReleaseSeptember 23, 2015 New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year WASHINGTON, D.C. — Today, the Ovarian Cancer National Alliance (OCNA) released groundbreaking new data in its report “50 States of Teal: Ovarian … Continued

Advocacy

Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) t...

Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday

October 16, 2015

For Immediate ReleaseSeptember 28, 2015 Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday WASHINGTON, D.C. — Tomorrow, Representatives Sean Duffy and Rosa DeLauro, who have each been … Continued

Advocacy

#30DaysofTeal Recap

#30DaysofTeal Recap

October 16, 2015

Missed a day during #30DaysofTeal? Click the plus sign to see everything we did during the month of September!

Community

Precision Medicine Initiative

Precision Medicine Initiative

October 16, 2015

In January’s State of the Union Address, President Obama ushered in an exciting phase in new medical research by introducing the Precision Medicine Initiative (PMI). This initiative will expand our understanding of personalized medicine, when doctors pick treatments to suit individual patients rather than the ‘one-size-fits-all’ approach. Since January, the President’s advisers have begun to … Continued

Advocacy

BRCA Mutations Confer Risk, Even in Absence of Family History

BRCA Mutations Confer Risk, Even in Absence of Family History

October 15, 2015

(October 15, 2015)  According to a Japanese study published in Cancer, BRCA1/2 gene mutations may be associated with an inherited risk of ovarian cancer regardless of family history. The researchers examined 95 women with ovarian cancer who were treated from 2013 to 2015.  BRCA1/2 gene mutation tests were performed with next-generation sequencing in order to determine a link … Continued

Research

Third Party Spotlight

Third Party Spotlight

October 14, 2015

On December 30-January 1, golfers from across the US will tee off for the Second Annual Joan Kidd MD Ovarian Cancer Awareness Cup at Pebble Beach Golf Links, Pebble Beach, California. The 2016 Awareness Cup will celebrate the life work of Dr. Kidd, who lost her battle to ovarian cancer this summer.  Dr. Kidd had a passion for raising ovarian cancer awareness and was a longtime volunteer to Shepherd’s Hope in Central Florida. Click the plus sign to register today.

Community

Most Women Getting BRCA Test not Getting Genetic Counseling

Most Women Getting BRCA Test not Getting Genetic Counseling

October 7, 2015

(October 7, 2015) A report published in JAMA Oncology shows that most commercially insured women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals.  Lack of clinician recommendation was the most commonly reported reason why they didn’t receive genetic counseling. The study authors examined the factors associated with use of … Continued

Research